Stock listing

Moderna, Inc.

Selected listing: MRNA · SIX · CHF · CH

Moderna, Inc. (SIX Swiss: MRNA), Health Technology. Latest release Oct 2, 2026: Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026.

MRNA:SIXCHFCHUpdated October 2, 2026

Ticker: SIX Swiss: MRNA
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: SIX Swiss
Currency: CHF

About Moderna, Inc.

Moderna, Inc. is a public company traded under the ticker MRNA in the American market. Moderna is known for its innovative work in biotechnology, particularly in the development of mRNA-based therapeutics and vaccines.

Latest news from Moderna, Inc.

Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026

October 1, 2026

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

September 29, 2026

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

September 30, 2026

Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026

September 21, 2026

Moderna to Present at Upcoming Conferences in September 2026

September 1, 2026

All Moderna, Inc. news →

Events

Replays

Moderna, Inc. (MRNA) Q2 2026 Earnings Call
Fri, Jul 31, 2026 · 08:00 AM ET
Watch
Moderna, Inc. (MRNA) Q1 2026 Earnings Call
Fri, May 01, 2026 · 08:00 AM ET
Watch
Moderna, Inc. (MRNA) Q4 2025 Earnings Call
Fri, Feb 13, 2026 · 08:00 AM ET
Watch

Research Moderna, Inc.

Moderna, Inc. company profile

View the public company page for Moderna, Inc. on 6ix.

Moderna, Inc. news

Read company news and market updates connected to Moderna, Inc..

Moderna, Inc. investor events

Find investor webinars, events, and replay context for Moderna, Inc..